Hypertension, pulmonary Trials in Dresden, Germany
Conditions / Hypertension, pulmonary / Dresden, Germany
Research into Hypertension, pulmonary spans multiple therapeutic approaches and trial phases.
20 total trials for this combination
Showing top 10 of 20 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00458276 | Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery | TERMINATED | PHASE3 |
| NCT00863681 | BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension | COMPLETED | PHASE3 |
| NCT00679224 | An Observational Study For Ambrisentan | COMPLETED | — |
| NCT04084678 | A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH | TERMINATED | PHASE3 |
| NCT01784562 | Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH) | NO_LONGER_AVAILABLE | — |
| NCT04945460 | A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16) | COMPLETED | — |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ENROLLING_BY_INVITATION | PHASE3 |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT01178073 | A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) | COMPLETED | PHASE3 |
| NCT04732221 | A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007) | COMPLETED | PHASE2/PHASE3 |